https://maexcelenciamedica.com.br/artigo/cardiotoxicity-of-monoclonal-antibody-based-therapies-in-breast-cancer-a-contemporary-narrative-review/ 2026-09-02T20:34:25+00:00 https://maexcelenciamedica.com.br/artigo/two-stage-risk-reducing-breast-surgery-with-a-synthetic-matrix-a-case-report/ 2026-09-02T20:35:28+00:00 https://maexcelenciamedica.com.br/artigo/reoperation-rates-following-breast-conserving-surgery-in-a-contemporary-cohort/ 2026-09-02T20:36:24+00:00 https://maexcelenciamedica.com.br/artigo/severe-adverse-events-in-neoadjuvant-therapy-of-triple-negative-breast-cancer-a-systematic-review-and-meta-analysis-of-randomized-phase-3-trials/ 2026-09-02T20:37:27+00:00 https://maexcelenciamedica.com.br/artigo/optimizing-axillary-lymph-node-management-in-early-stage-hr-her2-breast-cancer-practical-strategies-for-enhanced-detection-rates/ 2026-09-02T20:38:17+00:00 https://maexcelenciamedica.com.br/artigo/estudo-do-biomarcador-p16-no-carcinoma-de-mama-de-mulheres-submetidas-a-endocrinoterapia-primaria-de-curta-duracao-com-tamoxifeno-e-anastrozol/ 2026-09-02T18:56:31+00:00 https://maexcelenciamedica.com.br/artigo/estado-atual-da-biopsia-do-linfonodo-sentinela/ 2026-09-02T19:04:24+00:00 https://maexcelenciamedica.com.br/artigo/correlation-between-anthropometric-measures-and-biomarker-changes-after-neoadjuvant-therapy-with-tamoxifen-or-anastrozole-in-postmenopausal-women-with-breast-cancer/ 2026-09-02T19:04:53+00:00 https://maexcelenciamedica.com.br/artigo/short-term-anastrozole-therapy-reduces-ki-67-and-progesterone-receptor-expression-in-invasive-breast-cancer-a-prospective-placebo-controlled-double-blind-trial/ 2026-09-02T19:05:19+00:00 https://maexcelenciamedica.com.br/artigo/a-case-report-of-male-breast-cancer-in-a-very-young-patient-what-is-changing/ 2026-09-02T19:06:11+00:00 https://maexcelenciamedica.com.br/artigo/estrogen-receptor-alpha-beta-ratio-and-estrogen-receptor-beta-as-predictors-of-endocrine-therapy-responsiveness-a-randomized-neoadjuvant-trial-comparison-between-anastrozole-and-tamoxifen-for/ 2026-09-02T19:07:20+00:00 https://maexcelenciamedica.com.br/artigo/a-phase-iii-randomized-non-inferiority-study-comparing-the-efficacy-and-safety-of-biosimilar-filgrastim-versus-originator-filgrastim-for-chemotherapy-induced-neutropenia-in-breast-cancer-patients/ 2026-09-02T19:08:13+00:00 https://maexcelenciamedica.com.br/artigo/age-of-diagnosis-and-body-mass-index-in-breast-cancer-patients-analysis-of-a-brazilian-reference-centre/ 2026-09-02T19:10:16+00:00 https://maexcelenciamedica.com.br/artigo/fixed-dose-combination-of-pertuzumab-and-trastuzumab-for-subcutaneous-injection-plus-chemotherapy-in-her2-positive-early-breast-cancer-federica-a-randomised-open-label-multicentre-non-inferiorit/ 2026-09-02T19:10:47+00:00 https://maexcelenciamedica.com.br/artigo/how-long-does-it-take-to-start-breast-cancer-treatment-in-brazil-is-the-60-day-law-fulfilled/ 2026-09-02T19:12:16+00:00 https://maexcelenciamedica.com.br/artigo/epidemiology-of-male-breast-cancer-in-brazil-an-analysis-of-patients-undergoing-treatment-in-the-public-health-system/ 2026-09-02T19:12:36+00:00 https://maexcelenciamedica.com.br/artigo/prognostic-factors-and-survival-outcomes-of-patients-with-early-her2-breast-cancer-treated-with-trastuzumab-in-a-brazilian-public-reference-center-a-real-world-study/ 2026-09-02T19:13:06+00:00 https://maexcelenciamedica.com.br/artigo/real-world-evidence-of-neoadjuvant-chemotherapy-for-breast-cancer-treatment-in-a-brazilian-multicenter-cohort-correlation-of-pathological-complete-response-with-overall-survival/ 2026-09-02T19:13:37+00:00 https://maexcelenciamedica.com.br/artigo/randomized-clinical-trial-of-tissue-equivalent-bolus-prescription-in-postmastectomy-radiotherapy-stratified-by-skin-involvement-status/ 2026-09-02T19:13:58+00:00 https://maexcelenciamedica.com.br/artigo/sentinel-lymph-node-biopsy-following-neoadjuvant-chemotherapy-an-evidence-based-review-and-recommendations-for-current-practice/ 2026-09-02T19:14:17+00:00 https://maexcelenciamedica.com.br/artigo/systematic-review-of-nomograms-used-for-predicting-pathological-complete-response-in-early-breast-cancer/ 2026-09-02T19:14:39+00:00 https://maexcelenciamedica.com.br/artigo/impact-of-the-covid-19-pandemic-on-the-breast-cancer-early-diagnosis-program-in-brazil/ 2026-09-02T19:14:57+00:00 https://maexcelenciamedica.com.br/artigo/impact-of-neoadjuvant-chemotherapy-in-the-surgical-treatment-of-breast-cancer/ 2026-09-02T19:15:16+00:00 https://maexcelenciamedica.com.br/artigo/impact-of-neoadjuvant-chemotherapy-in-the-surgical-treatment-of-breast-cancer-errata/ 2026-09-02T19:15:40+00:00 https://maexcelenciamedica.com.br/artigo/integrative-review-of-clinical-trials-and-meta-analysis-of-the-main-studies-of-neoadjuvant-chemotherapy-in-the-treatment-of-breast-cancer-in-the-past-30-years/ 2026-09-02T19:15:59+00:00 https://maexcelenciamedica.com.br/artigo/vaccum-assisted-biopsy-for-breast-carcinoma-diagnosis-cost-minimization-analysis/ 2026-09-02T19:16:21+00:00 https://maexcelenciamedica.com.br/artigo/accuracy-of-stereotactic-vaccum-assisted-breast-biopsy-for-investigating-suspicious-calcifications-in-2021-patients-at-a-public-hospital-in-brazil/ 2026-09-02T19:16:42+00:00 https://maexcelenciamedica.com.br/artigo/real-world-evidence-of-predictors-of-pathologic-complete-response-and-impact-on-overall-survival-in-breast-cancer-patients-treated-with-neoadjuvant-chemotherapy/ 2026-09-02T19:17:00+00:00 https://maexcelenciamedica.com.br/artigo/clinical-and-pathological-differences-between-her2-low-and-other-cancer-subtypes-in-breast-cancer-patients/ 2026-09-02T19:17:18+00:00 https://maexcelenciamedica.com.br/artigo/knowledge-related-to-breast-cancer-screening-programs-by-physicians-in-brazil/ 2026-09-02T19:35:44+00:00 https://maexcelenciamedica.com.br/artigo/addressing-breast-cancer-disparities-in-brazil-a-roadmap-for-innovative-strategies/ 2026-09-02T19:36:09+00:00 https://maexcelenciamedica.com.br/artigo/two-years-post-covid-19-an-ecologic-study-evaluating-the-impact-on-brazils-mammographic-screening-program/ 2026-09-02T19:36:48+00:00 https://maexcelenciamedica.com.br/artigo/real-world-evidence-of-survival-outcomes-in-breast-cancer-subtypes-after-neoadjuvant-chemotherapy-in-a-brazilian-reference-center/ 2026-09-02T19:37:12+00:00 https://maexcelenciamedica.com.br/artigo/analyzing-neoadjuvant-chemotherapy-effects-in-her2-low-breast-cancer-real-world-data/ 2026-09-02T19:37:36+00:00 https://maexcelenciamedica.com.br/artigo/breast-and-axillary-marking-in-the-neoadjuvant-setting-survey-results-from-experts-of-the-brazilian-society-of-mastology/ 2026-09-02T19:38:04+00:00 https://maexcelenciamedica.com.br/artigo/selecting-postoperative-adjuvant-systemic-therapy-for-early%e2%80%90stage-breast-cancer-an-updated-assessment-and-systematic-review-of-leading-commercially-available-gene-expression-assays/ 2026-09-02T19:38:31+00:00 https://maexcelenciamedica.com.br/artigo/male-and-female-disparities-in-breast-cancer-epidemiology-a-comparative-cross-sectional-analysis-of-a-brazilian-cohort-2017-2021/ 2026-09-02T19:38:53+00:00 https://maexcelenciamedica.com.br/artigo/first-line-lenvatinib-plus-pembrolizumab-versus-chemotherapy-for-advanced-endometrial-cancer-a-randomized-open-label-phase-iii-trial/ 2026-09-02T19:39:12+00:00 https://maexcelenciamedica.com.br/artigo/assessment-of-the-relationship-between-metabolic-syndrome-and-breast-cancer/ 2026-09-02T19:39:40+00:00 https://maexcelenciamedica.com.br/artigo/breast-cancer-and-public-healthcare-survey-and-proposals-from-brazilian-society-of-mastology-sbm/ 2026-09-02T19:39:59+00:00 https://maexcelenciamedica.com.br/artigo/is-axillary-evaluation-still-necessary-in-ductal-carcinoma-in-situ/ 2026-09-02T19:40:26+00:00 https://maexcelenciamedica.com.br/artigo/impact-of-surgical-treatment-on-the-quality-of-life-of-female-public-employees-in-the-state-of-sao-paulo-after-breast-cancer-treatment-a-single-institution-cross-sectional-observational-study/ 2026-09-02T19:40:47+00:00 https://maexcelenciamedica.com.br/artigo/two-years-post-covid-19-evaluating-the-impact-on-brazils-breast-cancer-early-detection-program/ 2026-09-02T19:41:06+00:00 https://maexcelenciamedica.com.br/artigo/analysis-of-malignity-rates-of-percutaneous-biopsy-in-lymph-nodes-of-breast-cancer-patients/ 2026-09-02T19:41:26+00:00 https://maexcelenciamedica.com.br/artigo/breast-cancer-treatment-delays-in-brazil-an-ecological-study-from-2017-to-2022/ 2026-09-02T19:41:43+00:00 https://maexcelenciamedica.com.br/artigo/imlunestrant-with-or-without-abemaciclib-in-advanced-breast-cancer/ 2026-09-02T19:42:08+00:00 https://maexcelenciamedica.com.br/artigo/the-use-of-blue-dye-alone-for-sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-in-patients-with-initially-node-positive-breast-cancer/ 2026-09-02T19:42:28+00:00 https://maexcelenciamedica.com.br/artigo/postmastectomy-late-breast-reconstruction-with-transverse-rectus-abdominis-flap-after-primary-closure-with-latissimus-dorsi/ 2026-09-02T19:42:51+00:00 https://maexcelenciamedica.com.br/artigo/promriine-pre-operatory-magnetic-resonance-imaging-is-ineffective-study-a-systematic-review-and-meta-analysis-of-the-impact-of-magnetic-resonance-imaging-on-surgical-decisions-and-c/ 2026-09-02T19:43:10+00:00 https://maexcelenciamedica.com.br/artigo/real-world-evidence-of-ribociclib-plus-aromatase-inhibitors-as-first-line-treatment-in-advanced-breast-cancer-the-brasileeira-study/ 2026-09-02T19:43:27+00:00 https://maexcelenciamedica.com.br/artigo/advancing-preoperative-staging-in-early-breast-cancer-a-comparative-analysis-of-imaging-modalities/ 2026-09-02T19:49:04+00:00 https://maexcelenciamedica.com.br/artigo/assisted-breast-reconstruction-with-biosynthetic-mesh-and-implants-a-pilot-study/ 2026-09-02T19:49:23+00:00 https://maexcelenciamedica.com.br/artigo/barriers-to-breast-cancer-treatment-in-brazil-a-study-on-migration-and-regional-disparities%e2%98%86/ 2026-09-02T19:49:42+00:00 https://maexcelenciamedica.com.br/artigo/breast-cancer-stage-molecular-subtype-and-survival-in-patients-with-obesity-a-real-world-study/ 2026-09-02T19:50:02+00:00 https://maexcelenciamedica.com.br/artigo/bridging-gaps-in-breast-cancer-care-a-breast-cancer-care-quality-index-to-improve-outcomes-worldwide/ 2026-09-02T19:50:23+00:00 https://maexcelenciamedica.com.br/artigo/cadonot-comparing-axillary-dissection-or-not-in-breast-cancer-surgery/ 2026-09-02T19:50:51+00:00 https://maexcelenciamedica.com.br/artigo/clinical-characteristics-and-prognostic-impact-of-her2-low-expression-in-breast-cancer-subtypes-from-a-brazilian-real-world-cohort/ 2026-09-02T19:51:44+00:00 https://maexcelenciamedica.com.br/artigo/comparative-analyses-of-van-nuys-prognostic-index-and-nccn-guidelines-in-ductal-carcinoma-in-situ-treatment-in-a-brazilian-hospital/ 2026-09-02T19:52:05+00:00 https://maexcelenciamedica.com.br/artigo/cracking-the-code-pioneering-early-detection-and-management-of-breast-cancer-in-the-brazilian-public-healthcare-system/ 2026-09-02T19:52:23+00:00 https://maexcelenciamedica.com.br/artigo/the-relationship-between-body-mass-index-and-pathological-complete-response-in-brazilian-breast-cancer-patients/ 2026-09-02T19:52:59+00:00 https://maexcelenciamedica.com.br/artigo/disparities-in-access-to-anti-her2-therapies-in-neoadjuvant-chemotherapy-a-prognostic-analysis-based-on-real-world-data-comparing-brazils-public-and-private-healthcare-systems/ 2026-09-02T19:53:22+00:00 https://maexcelenciamedica.com.br/artigo/first-line-lenvatinib-plus-pembrolizumab-versus-chemotherapy-for-advanced-endometrial-cancer-1-year-follow-up-after-final-analysis-of-the-engot-en9-leap-001-phase-3-trial/ 2026-09-02T19:53:52+00:00 https://maexcelenciamedica.com.br/artigo/mammographic-screening-hero-or-villain/ 2026-09-02T19:54:48+00:00 https://maexcelenciamedica.com.br/artigo/hypofractionated-whole-and-partial-breast-irradiation-brazilian-society-of-radiotherapy-sbrt-consensus/ 2026-09-02T19:55:07+00:00 https://maexcelenciamedica.com.br/artigo/immunohistochemical-changes-after-neoadjuvant-chemotherapy-and-their-impact-on-breast-cancer-survival-a-systematic-review-and-meta-analysis/ 2026-09-02T19:55:26+00:00 https://maexcelenciamedica.com.br/artigo/is-axillary-surgery-still-justified-in-dcis-diagnosed-via-vacuum-assisted-biopsy/ 2026-09-02T19:55:49+00:00 https://maexcelenciamedica.com.br/artigo/national-survey-on-attitudes-of-brazilian-breast-surgeons-regarding-oncoplastic-surgery-success-of-a-training-model/ 2026-09-02T19:56:08+00:00 https://maexcelenciamedica.com.br/artigo/oncological-outcomes-of-breastconserving-surgery-versus-mastectomy-following-neoadjuvant-chemotherapy-in-a-contemporary-multicenter-cohort/ 2026-09-02T19:56:26+00:00 https://maexcelenciamedica.com.br/artigo/oncoplastic-surgery-in-the-treatment-of-breast-cancer-a-review-of-evolution-and-surgical-training/ 2026-09-02T19:56:43+00:00 https://maexcelenciamedica.com.br/artigo/overall-survival-and-economic-impact-of-triple-negative-breast-cancer-in-brazilian-public-health-care-a-real-world-study/ 2026-09-02T19:57:01+00:00 https://maexcelenciamedica.com.br/artigo/pathologic-complete-response-and-breast-cancer-survival-post-neoadjuvant-chemotherapy-a-systematic-review-and-meta-analysis-of-real-world-data/ 2026-09-02T19:57:26+00:00 https://maexcelenciamedica.com.br/artigo/prognostic-impact-of-real-world-immunohistochemical-changes-in-breast-cancer-treated-with-neoadjuvant-chemotherapy/ 2026-09-02T19:57:44+00:00 https://maexcelenciamedica.com.br/artigo/radiotherapy-in-breast-cancer-patients-achieving-nodal-pathologic-complete-response-after-neoadjuvant-therapy-a-scoping-review/ 2026-09-02T19:58:11+00:00 https://maexcelenciamedica.com.br/artigo/radiotherapy-in-breast-cancer-patients-achieving-nodal-pathologic-complete-response-after-neoadjuvant-therapy-a-scoping-review-2/ 2026-09-02T19:58:33+00:00 https://maexcelenciamedica.com.br/artigo/vacuum-assisted-excision-one-step-approach-to-the-diagnosis-and-percutaneous-treatment-of-small-early-breast-cancer-the-vae-breast-01-study-protocol/ 2026-09-02T19:58:56+00:00 https://maexcelenciamedica.com.br/artigo/trends-in-mastectomy-performance-for-early-breast-cancer-in-a-public-institution-with-limited-access-a-retrospective-cohort/ 2026-09-02T19:59:14+00:00 https://maexcelenciamedica.com.br/artigo/twenty-years-of-breast-cancer-epidemiology-and-treatment-patterns-in-sao-paulo-brazil-observed-versus-expected-treatment-utilization-in-a-retrospective-cohort/ 2026-09-02T19:59:35+00:00 https://maexcelenciamedica.com.br/artigo/vacuum-assisted-biopsy-in-the-era-of-low-risk-ductal-carcinoma-in-situ-active-monitoring-real-world-data-and-implications/ 2026-09-02T19:59:57+00:00 https://maexcelenciamedica.com.br/artigo/compliance-with-brazilian-law-12-732-assessing-breast-cancer-treatment-delays-across-different-therapeutic-modalities-2017-2022/ 2026-09-02T20:03:12+00:00 https://maexcelenciamedica.com.br/artigo/survival-outcomes-after-standard-breast-conserving-surgery-versus-oncoplastic-breast-conserving-surgery-in-breast-cancer-patients-a-multicenter-real-world-evidence-cohort-study/ 2026-09-02T20:03:31+00:00 https://maexcelenciamedica.com.br/artigo/core-needle-biopsy-versus-fine-needle-aspiration-for-lymph-node-evaluation-in-breast-cancer-diagnostic-accuracy-and-cost-analysis-in-a-public-health-system/ 2026-09-02T20:03:47+00:00 https://maexcelenciamedica.com.br/artigo/cost-minimization-analysis-of-vacuum-assisted-biopsy-versus-surgical-biopsy-for-the-diagnosis-of-suspicious-breast-lesions-in-the-brazilian-public-health-system/ 2026-09-02T20:04:02+00:00 https://maexcelenciamedica.com.br/artigo/first-line-lenvatinib-plus-pembrolizumab-versus-chemotherapy-for-advanced-endometrial-cancer-1-year-follow-up-after-final-analysis-of-the-engot-en9-leap-001-phase-3-trial-2/ 2026-09-02T20:04:26+00:00 https://maexcelenciamedica.com.br/artigo/immune-profiling-in-residual-disease-refining-risk-stratification-after-neoadjuvant-therapy-in-her2-positive-breast-cancer/ 2026-09-02T20:04:46+00:00 https://maexcelenciamedica.com.br/artigo/clinical-and-public-health-guidelines-from-the-2025-international-symposium-on-breast-diseases-of-inland-sao-paulo-strategies-for-early-breast-cancer-detection-and-her2-positive-treatment-within-braz/ 2026-09-02T20:05:06+00:00